Resources
State-of-the-art Plasmodium-adapted technology platforms
The MALDA Consortium is an innovative target-guided discovery platform linking phenotypic hits to function for malaria. MalDA has developed a collaborative pipeline, applying multiple biomedical, biotechnological, and cheminformatic approaches to the identification of novel drug targets. By sharing resources, including expertise, knowledge, materials, and reagents, the consortium strives to eliminate the structural barriers often encountered in the drug discovery process accelerating malaria drug development.
